Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study

Liviu Klein, Christopher M. O'Connor, Jeffrey D. Leimberger, Wendy Gattis-Stough, Ileana L. Pina, G. Michael Felker, Kirkwood F. Adams, Robert M. Califf, Mihai Gheorghiade

Research output: Contribution to journalArticle

349 Citations (Scopus)

Abstract

Background - The prognostic value of serum sodium in patients hospitalized for worsening heart failure has not been well defined. Methods and Results - The Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study randomized 949 patients with systolic dysfunction hospitalized for worsening heart failure to receive 48 to 72 hours of intravenous milrinone or placebo in addition to standard therapy. In a retrospective analysis, we investigated the relationship between admission serum sodium and the primary end point of days hospitalized for cardiovascular causes within 60 days of randomization, as well as the secondary end points of in-hospital mortality, 60-day mortality, and 60-day mortality/rehospitalization. The number of days hospitalized for cardiovascular causes was higher in the lowest sodium quartile: 8.0 (4.5, 18.5) versus 6 (4, 13) versus 6 (4, 11.5) versus 6 (4, 12) days (P<0.015 for comparison with the lowest quartile). Lower serum sodium was associated with higher in-hospital and 60-day mortality: 5.9% versus 1% versus 2.3% versus 2.3% (P<0.015) and 15.9% versus 6.4% versus 7.8% versus 7% (P=0.002), respectively. There was a trend toward higher mortality/rehospitalization for patients who were in the lowest sodium quartile. Multivariable-adjusted Cox proportional hazards analysis showed that serum sodium on admission, when modeled linearly, predicted increased 60-day mortality: sodium (per 3-mEq/L decrease) had a hazard ratio of 1.18 with a 95% CI of 1.03 to 1.36 (P=0.018). Conclusions - In patients hospitalized for worsening heart failure, admission serum sodium is an independent predictor of increased number of days hospitalized for cardiovascular causes and increased mortality within 60 days of discharge.

Original languageEnglish (US)
Pages (from-to)2454-2460
Number of pages7
JournalCirculation
Volume111
Issue number19
DOIs
StatePublished - May 17 2005
Externally publishedYes

Fingerprint

Milrinone
Heart Failure
Sodium
Mortality
Serum
Random Allocation
Hospital Mortality
Placebos

Keywords

  • Heart failure
  • Prognosis
  • Risk factors
  • Sodium

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure : Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. / Klein, Liviu; O'Connor, Christopher M.; Leimberger, Jeffrey D.; Gattis-Stough, Wendy; Pina, Ileana L.; Felker, G. Michael; Adams, Kirkwood F.; Califf, Robert M.; Gheorghiade, Mihai.

In: Circulation, Vol. 111, No. 19, 17.05.2005, p. 2454-2460.

Research output: Contribution to journalArticle

Klein, Liviu ; O'Connor, Christopher M. ; Leimberger, Jeffrey D. ; Gattis-Stough, Wendy ; Pina, Ileana L. ; Felker, G. Michael ; Adams, Kirkwood F. ; Califf, Robert M. ; Gheorghiade, Mihai. / Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure : Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. In: Circulation. 2005 ; Vol. 111, No. 19. pp. 2454-2460.
@article{d4ee01d85abe40a9aab9d2b6a734054c,
title = "Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study",
abstract = "Background - The prognostic value of serum sodium in patients hospitalized for worsening heart failure has not been well defined. Methods and Results - The Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study randomized 949 patients with systolic dysfunction hospitalized for worsening heart failure to receive 48 to 72 hours of intravenous milrinone or placebo in addition to standard therapy. In a retrospective analysis, we investigated the relationship between admission serum sodium and the primary end point of days hospitalized for cardiovascular causes within 60 days of randomization, as well as the secondary end points of in-hospital mortality, 60-day mortality, and 60-day mortality/rehospitalization. The number of days hospitalized for cardiovascular causes was higher in the lowest sodium quartile: 8.0 (4.5, 18.5) versus 6 (4, 13) versus 6 (4, 11.5) versus 6 (4, 12) days (P<0.015 for comparison with the lowest quartile). Lower serum sodium was associated with higher in-hospital and 60-day mortality: 5.9{\%} versus 1{\%} versus 2.3{\%} versus 2.3{\%} (P<0.015) and 15.9{\%} versus 6.4{\%} versus 7.8{\%} versus 7{\%} (P=0.002), respectively. There was a trend toward higher mortality/rehospitalization for patients who were in the lowest sodium quartile. Multivariable-adjusted Cox proportional hazards analysis showed that serum sodium on admission, when modeled linearly, predicted increased 60-day mortality: sodium (per 3-mEq/L decrease) had a hazard ratio of 1.18 with a 95{\%} CI of 1.03 to 1.36 (P=0.018). Conclusions - In patients hospitalized for worsening heart failure, admission serum sodium is an independent predictor of increased number of days hospitalized for cardiovascular causes and increased mortality within 60 days of discharge.",
keywords = "Heart failure, Prognosis, Risk factors, Sodium",
author = "Liviu Klein and O'Connor, {Christopher M.} and Leimberger, {Jeffrey D.} and Wendy Gattis-Stough and Pina, {Ileana L.} and Felker, {G. Michael} and Adams, {Kirkwood F.} and Califf, {Robert M.} and Mihai Gheorghiade",
year = "2005",
month = "5",
day = "17",
doi = "10.1161/01.CIR.0000165065.82609.3D",
language = "English (US)",
volume = "111",
pages = "2454--2460",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "19",

}

TY - JOUR

T1 - Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure

T2 - Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study

AU - Klein, Liviu

AU - O'Connor, Christopher M.

AU - Leimberger, Jeffrey D.

AU - Gattis-Stough, Wendy

AU - Pina, Ileana L.

AU - Felker, G. Michael

AU - Adams, Kirkwood F.

AU - Califf, Robert M.

AU - Gheorghiade, Mihai

PY - 2005/5/17

Y1 - 2005/5/17

N2 - Background - The prognostic value of serum sodium in patients hospitalized for worsening heart failure has not been well defined. Methods and Results - The Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study randomized 949 patients with systolic dysfunction hospitalized for worsening heart failure to receive 48 to 72 hours of intravenous milrinone or placebo in addition to standard therapy. In a retrospective analysis, we investigated the relationship between admission serum sodium and the primary end point of days hospitalized for cardiovascular causes within 60 days of randomization, as well as the secondary end points of in-hospital mortality, 60-day mortality, and 60-day mortality/rehospitalization. The number of days hospitalized for cardiovascular causes was higher in the lowest sodium quartile: 8.0 (4.5, 18.5) versus 6 (4, 13) versus 6 (4, 11.5) versus 6 (4, 12) days (P<0.015 for comparison with the lowest quartile). Lower serum sodium was associated with higher in-hospital and 60-day mortality: 5.9% versus 1% versus 2.3% versus 2.3% (P<0.015) and 15.9% versus 6.4% versus 7.8% versus 7% (P=0.002), respectively. There was a trend toward higher mortality/rehospitalization for patients who were in the lowest sodium quartile. Multivariable-adjusted Cox proportional hazards analysis showed that serum sodium on admission, when modeled linearly, predicted increased 60-day mortality: sodium (per 3-mEq/L decrease) had a hazard ratio of 1.18 with a 95% CI of 1.03 to 1.36 (P=0.018). Conclusions - In patients hospitalized for worsening heart failure, admission serum sodium is an independent predictor of increased number of days hospitalized for cardiovascular causes and increased mortality within 60 days of discharge.

AB - Background - The prognostic value of serum sodium in patients hospitalized for worsening heart failure has not been well defined. Methods and Results - The Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study randomized 949 patients with systolic dysfunction hospitalized for worsening heart failure to receive 48 to 72 hours of intravenous milrinone or placebo in addition to standard therapy. In a retrospective analysis, we investigated the relationship between admission serum sodium and the primary end point of days hospitalized for cardiovascular causes within 60 days of randomization, as well as the secondary end points of in-hospital mortality, 60-day mortality, and 60-day mortality/rehospitalization. The number of days hospitalized for cardiovascular causes was higher in the lowest sodium quartile: 8.0 (4.5, 18.5) versus 6 (4, 13) versus 6 (4, 11.5) versus 6 (4, 12) days (P<0.015 for comparison with the lowest quartile). Lower serum sodium was associated with higher in-hospital and 60-day mortality: 5.9% versus 1% versus 2.3% versus 2.3% (P<0.015) and 15.9% versus 6.4% versus 7.8% versus 7% (P=0.002), respectively. There was a trend toward higher mortality/rehospitalization for patients who were in the lowest sodium quartile. Multivariable-adjusted Cox proportional hazards analysis showed that serum sodium on admission, when modeled linearly, predicted increased 60-day mortality: sodium (per 3-mEq/L decrease) had a hazard ratio of 1.18 with a 95% CI of 1.03 to 1.36 (P=0.018). Conclusions - In patients hospitalized for worsening heart failure, admission serum sodium is an independent predictor of increased number of days hospitalized for cardiovascular causes and increased mortality within 60 days of discharge.

KW - Heart failure

KW - Prognosis

KW - Risk factors

KW - Sodium

UR - http://www.scopus.com/inward/record.url?scp=18844423537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844423537&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000165065.82609.3D

DO - 10.1161/01.CIR.0000165065.82609.3D

M3 - Article

C2 - 15867182

AN - SCOPUS:18844423537

VL - 111

SP - 2454

EP - 2460

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 19

ER -